Enovis (ENOV) Common Equity (2010 - 2026)
Enovis' (ENOV) quarterly Common Equity came in at $1.5 billion in Q2 2026, down 43.63% year-on-year from $2.6 billion in Q2 2025, and down 1.0% on a QoQ basis from $1.5 billion in Q4 2025.
Enovis (ENOV) Common Equity (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Common Equity data on file, last reported at $1.5 billion in Q2 2026.
- On a quarterly basis, Common Equity fell 43.63% year-over-year to $1.5 billion in Q2 2026; TTM through Apr 2026 was $1.5 billion, a 43.63% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 41.82% from the prior year.
- Common Equity for Q2 2026 stood at $1.5 billion, down from $1.5 billion in the prior quarter.
- Over the last five years, Common Equity for ENOV reached as high as $4.6 billion in Q2 2022 and fell as low as $1.5 billion in Q2 2026.
- Historically, Common Equity has averaged $3.0 billion across 5 years, with a median of $3.3 billion in 2024.
- Across the five-year window, Common Equity grew 8.23% in 2022 and tumbled 43.63% in 2026, its largest moves.
- Year by year, Common Equity stood at $3.4 billion in 2022, then retreated by 0.84% to $3.4 billion in 2023, then decreased by 25.03% to $2.6 billion in 2024, then plunged by 41.82% to $1.5 billion in 2025, then slipped by 1.0% to $1.5 billion in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $1.5 billion in Q2 2026, $1.5 billion in Q4 2025, and $2.0 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 1.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.48 Bn |
| Dec 31, 2025 | 1.49 Bn |
| Oct 3, 2025 | 2.02 Bn |
| Jul 4, 2025 | 2.58 Bn |
| Apr 4, 2025 | 2.62 Bn |
| Dec 31, 2024 | 2.56 Bn |
| Sep 27, 2024 | 3.33 Bn |
| Jun 28, 2024 | 3.29 Bn |
| Mar 29, 2024 | 3.31 Bn |
| Dec 31, 2023 | 3.42 Bn |
| Sep 29, 2023 | 3.44 Bn |
| Jun 30, 2023 | 3.45 Bn |
| Mar 31, 2023 | 3.45 Bn |
| Dec 31, 2022 | 3.45 Bn |
| Sep 30, 2022 | 3.41 Bn |
| Jul 1, 2022 | 3.49 Bn |
| Apr 1, 2022 | 4.64 Bn |
| Dec 31, 2021 | 4.66 Bn |
| Oct 1, 2021 | 4.63 Bn |
| Jul 2, 2021 | 4.35 Bn |